The Ranbaxy vs. Pfizer battle is worth watching.
http://www.theday.com/eng/web/news/re.aspx?re=F37D48D0-51F2-4AE9-A843-D8412975E0AF
Pfizer Inc. said Tuesday that it planned to vigorously defend its best-selling Lipitor drug against claims by an Indian generic-drug manufacturer that it can market its own version of the cholesterol-lowering medication.
Pfizer will square off against Ranbaxy Laboratories Ltd. next Tuesday in federal district court in Delaware, where Ranbaxy's attorneys will challenge Pfizer's patents on Lipitor, the world's top-selling drug, which generated sales of more than $9 billion this past year.
Pfizer had filed legal briefs seeking to dismiss the suit but was denied. The case is a significant one for Pfizer because of the huge success of Lipitor, the drug of choice among many of the world's physicians to lower cholesterol.
The Wall Street Journal said in a story in Tuesday's edition that analysts have called the Pfizer challenge by the generic drugmaker a long shot, but that if it prevailed it would send shock waves throughout the pharmaceutical industry.
Wednesday, November 24, 2004
Subscribe to:
Post Comments (Atom)
Followers
Blog Archive
-
▼
2004
(54)
-
▼
November
(36)
- United Nations
- Brazil's Bomb -- with Indian help?
- Pakistan's Hamid Gul
- Bharateeya Blog Mela
- Patriot Missiles
- Pogrom in Gujarat
- Kashmir
- Global Commerce
- United Nations
- Environment
- Culture
- United Nations
- China
- Hip Hinglish
- India Terror Warning
- Pogrom in Gujarat
- Neo-conservatism
- The Shia Bomb
- United Nations
- Energy and Environment
- Custodians of Culture
- Murder in Kanchi
- Kashmir
- Murder in Kanchi
- Corruption
- China
- Democracy
- Corruption
- Head and Heart
- The Bush Revolution
- United Nations
- United Nations
- Indo-US relationship
- Neo-conservatism
- Kashmir
- Whose blog is this?
-
▼
November
(36)
No comments:
Post a Comment